Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Indolinone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118878452B reveals mild synthesis for antitumor intermediates. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN115353511A details a safe, multicomponent Pd-catalyzed carbonylation route for indolinone-imidazole hybrids, offering cost reduction in API manufacturing.
Patent CN115353511A details a novel multi-component Pd-catalyzed carbonylation for synthesizing indolinone-imidazole hybrids, offering cost-effective routes for API intermediates.
Novel Pd-catalyzed multicomponent method for trifluoromethyl indolinone-imidazoles. High yield, mild conditions, scalable process for pharma intermediates.
Novel Pd-catalyzed multicomponent method for indolinone-imidazole derivatives. Safe, scalable, CO-free process for high-purity pharmaceutical intermediates.
Patent CN115353511A discloses a safe, multi-component palladium-catalyzed method for synthesizing carbonyl-bridged biheterocycles using in-situ carbon monoxide generation.
Discover the copper-catalyzed synthesis of 3-methyleneisoindolinone derivatives. A cost-effective, green route for pharmaceutical intermediates with removable directing groups.
Patent CN115353511A reveals a safe Pd-catalyzed carbonylation method for synthesizing indolinone-imidazole hybrids, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN115353511A details a safe, one-pot palladium-catalyzed carbonylation method for synthesizing complex biheterocycles, offering significant cost and safety advantages.
Novel palladium-catalyzed route offers cost reduction in pharmaceutical intermediate manufacturing with enhanced supply chain reliability and high purity standards for global buyers.
Patent CN115353511A details a novel Pd-catalyzed multicomponent synthesis for carbonyl-bridged biheterocycles, offering safer conditions and cost reduction in API manufacturing.
Patent CN110437128B details a mild Ni(II) method for 3-thioether isoindolinones, offering high yields and cost-effective manufacturing for pharmaceutical supply chains.
Patent CN115353511A details a novel Pd-catalyzed multicomponent synthesis for carbonyl-bridged biheterocycles, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113735756A details a novel Rh-catalyzed [4+1] cyclization for high-purity chiral isoindolinones, offering significant cost reduction in API manufacturing.
Patent CN110467556B reveals a mild Ni(II) catalytic route for 3-substituted isoindolinones, offering significant cost reduction in API manufacturing and scalable production capabilities.
Patent CN115353511A details a novel Pd-catalyzed multi-component route for carbonyl-bridged biheterocycles, offering safer conditions and cost reduction in API manufacturing.
Patent CN115286556B reveals green Pd-catalyzed route. Cost-effective, scalable indolinone intermediates for pharma manufacturing supply chains.
Novel palladium-catalyzed method for carbonyl-bridged biheterocycles avoids toxic CO gas. Offers cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN115353511A details a safe Pd-catalyzed multicomponent route avoiding toxic CO gas, offering cost reduction in API manufacturing and scalable production.
Patent CN115353511A details a novel Pd-catalyzed multicomponent synthesis for carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and enhanced supply chain reliability.